I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Leave site
Roche and Genentech at

Macula Society 2025

We will be contributing to topics related to
-
09:04 PM
Duration 5mins United States
Treatment Response and Safety of Faricimab▼ in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the US
Scott A, Amador M, Brown J, Cunningham M, Coney J, Emanuelli A, Huddleston S, Milunovich S, Yang M, Lu XY, Gonzalez L
09:09 PM
Duration 5mins United States
Four-Year Outcomes of Faricimab▼ in DME: Safety and Efficacy Results From The RHONE-X Long-Term Extension Trial
Khanani A, Abreu F, Gibson K, Kotak A, Lai TYY, Pearce I, Schlottmann P, Sim D, Tang Y, Kotecha A
09:14 PM
Duration 5mins United States
Greater reduction in hard exudates with faricimab▼ vs aflibercept in patients with DME: biomarker results from the phase 3 YOSEMITE/RHINE trials
Elman M, Pollreisz A, Dinah C, Goldberg R, Ip M, Rahimy E, Vujosevic S, Amador M, Gibson K, Maunz A, O'Leary O, Uschner D
01:50 PM
Duration 5mins United States
Impact of Early Intraretinal Fluid Reduction on One-Year Outcomes in Diabetic Macular Edema
Chan C, Sadda V, Lim J, Wang Y, Hibar D, Maunz A, Lu H, Albrecht T, Gibson K, Litts K
12:25 PM
Duration 5mins United States
Global Real-World Clinical and Anatomical Outcomes With Faricimab▼ in Treatment-Nave Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema From a Multi-Country Prospective Non-Interventional Study: The VOYAGER Study
Steffen Schmitz-Valckenberg, Clare Bailey, Voraporn Chaikitmongkol, Varun Chaudhary, Gloria Chi, Amanda Downey, Robert Finger, Roberto Gallego-Pinazo, Adrian Koh, Susumu Ishida, Monica Lövestam-Adrian, Mariacristina Parravano, Jose Luna Pinto, Veeral Sheth, Beijue Shi, Eric Souied, Diane Uschner, Robyn Guymer
12:30 PM
Duration 5mins United States
Treatment Patterns, Visual Outcomes, and Safety in Eyes With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) Treated With Faricimab▼ in the UK: 1-Year Results From the Faricimab▼ Real-World Evidence (FARWIDE) Study
Sivaprasad S, Pearce I, Talks J, Salvo G, Patel P, Silva S, Gale R, McKibbin M, Varma D, Peto T, Reynolds R, Bailey C, Downey L, Kiire C, Chi G, Dodds M, James N, Downey A, Dayal P
12:35 PM
Duration 5mins United States
Real-World Clinical and Anatomical Outcomes Update in Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) Treated With Faricimab▼ in the US: The FARETINA Study
Borkar D, Zwick E, Bonine N, Leng T, Ko S, Shaia J, Ali F, Singh R
02:50 PM
Duration 10mins United States
Function & Anatomy Fibrosis, MA, and fluid [Combo]
Arevalo JF, Chakravarthy U, Rachitskaya A, Holekamp N, Blotner S, Garcia Armendariz B, Heinrich D
03:20 PM
Duration 10mins United States
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis
Wells J, Keane P, Holekamp N, Leng T, Siedlecki J, Mar F, Gibson K, Margaron P, Paulo T, Buehrer C, Tabano D
03:40 PM
Duration 10mins United States
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-nave nAMD: TENAYA/LUCERNE Post Hoc Analyses
Tan C, Gallego-Pinazo R, Koh A, Pitcher J, Dagincourt N, Hill L, Patel S, Margaron P
03:50 PM
Duration 10mins United States
Faricimab▼ for Polypoidal Choroidal Vasculopathy: Week 16 Results From the Phase 3b/4 SALWEEN Trial
Cheung G, Chen SJ, Iida T, Koh A, Lee WK, Ruamviboonsuk P, Sun X, Yanagi Y, Bai R, Margaron P, Nguyen Duc A, Lai TYY
09:20 PM
Duration 5mins United States
A novel intravitreal anti-IL-6 monoclonal antibody for UME: preliminary results from the phase 1 DOVETAIL study
Holecamp N, Lin P, Steeples L, Elze M, Macgregor L, Stoilov I, Silverman D, Mesquida M, Haskova Z
02:35 PM
Duration 5mins United States
Mitigation of endoph: Surgical evolution
Chaudhry N, Campochiaro P, Chang M, Pieramici P, Regillo C, Bobbala A, Gune S, Jaycock P, Kardatzke D, Prager A, Singh N
04:20 PM
Duration 10mins United States
Pagoda Fluid and Fluid Fluctuations (Pagoda)
Tan G, D Marcus, Awh C, Eter N, Hatz K, Menezes A, Eghoej M, Gordon A, Blotner S, Heinrich D
Coming soon